Yalakanti [16] indicated that patients with T2DM might have mutations in the gene encoding type II 5′-deiodinase, which caused a decrease in enzyme activity, and lead to a significant reduction of FT3. The gene discussed is DIO2; the disease is type 2 diabetes mellitus.